In early session trading, shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) have slipped lower. Company stock has moved down -9.18% since the open, landing shares on today’s list of top losers. Investors will be watching to see if the stock can change direction heading into the second half of the session.Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is seeing declines so far in today’s trading session. Shares are moving -9.18% lower on solid volume. The stock has landed on the top loser list for the day according to Finviz data.
Ultragenyx Pharmaceutical Inc.(NASDAQ:RARE)‘s stock has performed at -30.78% year to date. Breaking that down further, it has performed 3.09% for the week, -9.79% for the month, -20.19% over the last quarter, -18.04% for the past half-year and -40.69% for this last year.
Ultragenyx Pharmaceutical Inc.’s stock is -8.53% away from its 20-Day Simple Moving Average. Extending back, their stock is trading -13.91% from the 50-Day Simple Moving Average, looking even further back, they are trading -29.11% off of the 200-Day Simple Moving Average. In comparing the current level to recent highs and lows, the stock is -23.79% from the 50-Day High and -0.56% off the 50-day low.
We should also note their 52-Week High and Low: the shares currently trade -51.61% away from their high and -0.56% from the low.
Considering the above information, analysts have given a consensus recommendation of 2.20. This is according to the brokerage firms polled by Thomson Reuters.